Pharmaceutical composition for treating osteoporosis of postmenopausal woman

An osteoporosis and composition technology, applied in the field of medicine, can solve the problems of high medical expenses and high disability rate, and achieve the effects of short course of treatment, less recurrence, and obvious effect.

Inactive Publication Date: 2014-11-26
逄海东
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although most osteoporosis does not directly cause death, its greatest harm is fracture, which brings "two highs": high disability rate and high medical expenses
Currently there is a lack of Chinese patent medicines mainly used for postmenopausal osteoporosis in the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating osteoporosis of postmenopausal woman
  • Pharmaceutical composition for treating osteoporosis of postmenopausal woman
  • Pharmaceutical composition for treating osteoporosis of postmenopausal woman

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 Drynaria 120g, Dodder 150g, Raspberry 150g, Salvia miltiorrhiza 150g, Angelica 180g, Astragalus 150g, Morinda officinalis 120g, Polygonum multiflorum 100g.

[0041] The preparation method of the granules of the present invention: take the raw materials of the above pharmaceutical composition, mix them evenly, pulverize them into 10-20 mesh coarse particles, add 6 times of water, extract three times in a row at 60°C by microwave extraction method, carry out centrifugal separation of the extract, and clean the infusion Concentrate to a thick paste with a relative density of 1.30-1.35, vacuum dry, crush the dry paste, then add compressible starch, sodium carboxymethylcellulose, mix and pass through an 80-mesh sieve, add appropriate amount of water to granulate, and depressurize at 60°C Dried, granulated, ready to serve.

Embodiment 2

[0042] Example 2 Rhizoma Drynariae 110g, Dodder 140g, Raspberry 140g, Salvia miltiorrhiza 140g, Angelica 170g, Astragalus 140g, Morinda officinalis 110g, Polygonum multiflorum 90g.

[0043] The preparation method of the capsule of the present invention: take the raw materials of the above pharmaceutical composition, mix them evenly, pulverize them into 10-20 mesh coarse particles, add 6 times of water, extract three times in a row at 60°C by microwave extraction method, centrifuge the extract, and clean the infusion Concentrate to a thick paste with a relative density of 1.30 to 1.35, dry it in vacuum, crush the dry paste, and pack it into capsules.

Embodiment 3

[0044]Example 3 Drynaria 130g, Dodder 160g, Raspberry 160g, Salvia miltiorrhiza 160g, Angelica 160g, Astragalus 160g, Morinda officinalis 130g, Polygonum multiflorum 110g.

[0045] The preparation method of the tablet of the present invention: take the raw materials of the above pharmaceutical composition and mix them evenly, pulverize them into 10-20 mesh coarse particles, add 6 times of water, extract three times in a row at 60°C by microwave extraction method, carry out centrifugal separation of the extract, and clean the infusion Concentrate to a thick paste with a relative density of 1.30-1.35, vacuum-dry, crush the dry paste, add appropriate amount of starch, talcum powder and magnesium stearate, granulate, compress into tablets, and coat to obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition for treating osteoporosis of a postmenopausal woman. The pharmaceutical composition is prepared from the components: rhizoma drynariae, dodder, raspberry, salvia, Angelica sinensis, astragalus, morinda officinalis how and tuberfleeceflower. The pharmaceutical composition has dosage forms of hard capsule, tablet and granule. The invention aims to provide a drug for treating the osteoporosis with exact curative effect.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for treating postmenopausal women's osteoporosis and a preparation method thereof. Background technique [0002] Postmenopausal osteoporosis (PMOP) is a common disease in middle-aged and elderly women. The risk of osteoporosis in middle-aged and elderly women due to menopause is significantly higher than that in men. Although most osteoporosis does not directly cause death, its greatest harm is fracture, which brings "two highs": high disability rate and high medical expenses. Currently, there is a lack of Chinese patent medicines mainly used for postmenopausal osteoporosis in the market. Contents of the invention [0003] The object of the present invention is to provide a new traditional Chinese medicine for treating postmenopausal women's osteoporosis and a preparation method thereof, so as to relieve sufferings of patients and create good s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/746A61P19/10
Inventor 逄海东
Owner 逄海东
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products